JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 178 filers reported holding JUNO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.38 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $104,000 | +35.1% | 2,282 | +33.6% | 0.00% | 0.0% |
| Q3 2017 | $77,000 | +63.8% | 1,708 | +8.6% | 0.00% | +100.0% |
| Q2 2017 | $47,000 | +176.5% | 1,573 | +101.7% | 0.00% | 0.0% |
| Q1 2017 | $17,000 | +240.0% | 780 | +226.4% | 0.00% | – |
| Q4 2016 | $5,000 | -28.6% | 239 | +3.9% | 0.00% | – |
| Q3 2016 | $7,000 | -22.2% | 230 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | – | 230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|